Thromboelastography During Surgery for Malignant Pleural Mesothelioma

Thromboelastography During Surgery for Malignant Pleural Mesothelioma

Surgery for malignant pleural mesothelioma is complex and prolonged, and may involve significant blood loss with considerable blood and product transfusion. Thromboelastography (TEG) is a global assay of coagulation that uses whole blood to produce a tracing that records kinetic changes in clot formation. This study aims provide a better understanding of the coagulation profile of these patients, and will form the basis of a TEG-based transfusion algorithm for future surgeries for mesothelioma.

Thromboelastography can provide more in-depth and quicker analysis of the complex coagulation processes during surgery

Inclusion Criteria:

• Adult male or female patients undergoing elective surgery for malignant pleural mesothelioma

Exclusion Criteria:

• Unwilling or unable to provide consent
• History of bleeding disorder
• On medications that may affect hemostasis